v3.26.3
Warrants
9 Months Ended
Sep. 30, 2026
Warrants and Rights Note Disclosure [Abstract]  
Warrants

Note 11 – Warrants

 

The Company issued warrants to OC III LFE II LP (“OC III LFE”) and various affiliates of OC III LFE (collectively, the “Warrantholder”) in previous years to purchase a number of shares of Common Stock equal to 23% (the “2020 Warrant”), 5% (the “2021 Warrant”), and 5% (the “2022 Warrant”) of the outstanding Common Stock (after giving effect to such issuance) on a fully-diluted basis at the time the warrants are exercised. Each warrant has an exercise price of $0.01 per share and a term of ten years from its date of issuance.

 

On June 26, 2026, the Warrantholder partially exercised the 2020 Warrant, the 2021 Warrant and the 2022 Warrant through the net exercise provisions contained in each warrant agreement. The exercised portions represented 22.99% of the Company's Common Stock Deemed Outstanding under the 2020 Warrant and 4.99% of the Company's Common Stock Deemed Outstanding under each of the 2021 Warrant and the 2022 Warrant. As a result of the net exercise, the Company issued 13,619,377 shares of Common Stock and no cash proceeds were received. The Company derecognized the portion of the warrant liability associated with the exercised warrants, with a corresponding increase to stockholders' equity.

 

In connection with the partial exercise, the Company issued three amended and restated replacement warrants (collectively, the “Replacement Warrants” and individually a “Replacement Warrant”), each representing the remaining unexercised portion of the original warrants equal to 0.01% of the Company's Common Stock Deemed Outstanding, with terms otherwise substantially identical to the original warrants.

 

As of September 30, 2026, each Replacement Warrant was exercisable for an aggregate of 4,157 shares of Common Stock, compared with 9,614,145 shares issuable under the original 2020 Warrant and 2,090,032 shares issuable under each of the original 2021 Warrant and the 2022 Warrant as of December 31, 2025.

 

The Company also issued a warrant to the Warrantholder in May 2023 to purchase an aggregate of 1,636,313 shares of Common Stock (the “2023 Warrant”). The 2023 Warrant has a per-share exercise price of $3.57 and a term of ten years from the date of issuance. The 2023 Warrant was not exercised or otherwise modified in connection with the June 2026 partial exercise of the 2020 Warrant, the 2021 Warrant and the 2022 Warrant.

 

The Replacement Warrants, together with the 2023 Warrant, are collectively referred to herein as the “Warrants.” The Warrants are classified as liabilities and remeasured at fair value at each reporting date. The aggregate warrant liability was $9,306 and $168,529 as of September 30, 2026 and December 31, 2025, respectively. Changes in the fair value of the Warrants are reported as a separate line item in the condensed consolidated statements of operations.